Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9J. H. M. Schellens, A-R Hanauske, P Dombernowsky et al.|Anti-Cancer Drugs|2001Cited by 13
Population Pharmacokinetic and Dynamic Analysis of the Topoisomerase I Inhibitor Lurtotecan in Phase II StudiesJan H.M. Schellens, Axel‐R. Hanauske, S.B. Kaye et al.|Investigational New Drugs|2002Cited by 10